Instil Bio TIL
NASDAQ TIL
$6.31 -0.04 (-0.63%)
At close: Nov 11, 2026 · 4:00 PM EST

Instil Bio (TIL) Cash from Restructuring (2022 - 2024)

Updated

Instil Bio (TIL) reported Cash from Restructuring of -$853,000 for Q2 2024, compared with -$1.67 million a year earlier.

Analysis

Instil Bio (TIL) Cash from Restructuring (2022 - 2024) Analysis & Trends

Over the twelve months ended Jun 30, 2024, Instil Bio's Cash from Restructuring came in at -$494,000; for FY2023, it came in at -$2.3 million.

  • By year, Cash from Restructuring came in at $5.43 million in FY2022.
  • Five-year quarterly Cash from Restructuring spans a low of -$1.67 million in Q2 2023 and a high of $5.43 million in Q4 2022.
  • Per Business Quant data, the three quarters before Q2 2024 came in at $778,000 (Q1 2024), -$52,000 (Q4 2023) and -$367,000 (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Instil Bio 43.07 Mn -256.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 75,000.00
Jun 30, 2024 -853,000.00
Mar 31, 2024 778,000.00
Dec 31, 2023 -52,000.00
Sep 30, 2023 -367,000.00
Jun 30, 2023 -1.67 Mn
Mar 31, 2023 -207,000.00
Dec 31, 2022 5.43 Mn
API Access

Instil Bio Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=TIL&period=max&api_key=YOUR_API_KEY